Cargando…
S-propargyl-cysteine attenuates inflammatory response in rheumatoid arthritis by modulating the Nrf2-ARE signaling pathway
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder. Hydrogen sulfide (H(2)S), the third physiological gasotransmitter, is well recognized as an anti-inflammatory mediator in various inflammatory conditions. Herein, we explored the protective effects of S-propargyl-cysteine (SPRC...
Autores principales: | Wu, Wei-Jun, Jia, Wan-Wan, Liu, Xin-Hua, Pan, Li-Long, Zhang, Qiu-Yan, Yang, Di, Shen, Xiao-Yan, Liu, Liang, Zhu, Yi Zhun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066299/ https://www.ncbi.nlm.nih.gov/pubmed/27744121 http://dx.doi.org/10.1016/j.redox.2016.08.011 |
Ejemplares similares
-
S-Propargyl-Cysteine Remodels the Gut Microbiota to Alleviate Rheumatoid Arthritis by Regulating Bile Acid Metabolism
por: Wang, Zhou, et al.
Publicado: (2021) -
Effects of S-Propargyl-Cysteine (SPRC) in Caerulein-Induced Acute Pancreatitis in Mice
por: Sidhapuriwala, Jenab N., et al.
Publicado: (2012) -
S-Propargyl-Cysteine, a Novel Hydrogen Sulfide Donor, Inhibits Inflammatory Hepcidin and Relieves Anemia of Inflammation by Inhibiting IL-6/STAT3 Pathway
por: Wang, Minjun, et al.
Publicado: (2016) -
S-Propargyl-cysteine Exerts a Novel Protective Effect on Methionine and Choline Deficient Diet-Induced Fatty Liver via Akt/Nrf2/HO-1 Pathway
por: Li, Wenwen, et al.
Publicado: (2016) -
H(2)S Donor, S-Propargyl-Cysteine, Increases CSE in SGC-7901 and Cancer-Induced Mice: Evidence for a Novel Anti-Cancer Effect of Endogenous H(2)S?
por: MA, Kaium, et al.
Publicado: (2011)